Vir Biotechnology, Inc. VIR Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s financing cash flow?
- Vir Biotechnology, Inc. (VIR) reported financing cash flow of $162.52M in Q1 2026.
- How has Vir Biotechnology, Inc.'s financing cash flow changed year-over-year?
- Vir Biotechnology, Inc.'s financing cash flow increased by 27077.8% year-over-year, from $598K to $162.52M.
- What is the long-term trend for Vir Biotechnology, Inc.'s financing cash flow?
- Over 4 years (2021 to 2025), Vir Biotechnology, Inc.'s financing cash flow has grown at a -55.9% compound annual growth rate (CAGR), from $100.33M to $3.79M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.